Cite
Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.
MLA
Feng Xiao, et al. “Efficacy and Safety of Homoharringtonine plus Cytarabine and Aclarubicin for Patients with Myelodysplastic Syndrome-RAEB.” Oncology Letters, vol. 11, no. 1, Jan. 2016, pp. 355–59. EBSCOhost, https://doi.org/10.3892/ol.2015.3876.
APA
Feng Xiao, Ying Li, Weilai Xu, Liangshun You, Chunmei Yang, Hui Liu, & Wenbin Qian. (2016). Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB. Oncology Letters, 11(1), 355–359. https://doi.org/10.3892/ol.2015.3876
Chicago
Feng Xiao, Ying Li, Weilai Xu, Liangshun You, Chunmei Yang, Hui Liu, and Wenbin Qian. 2016. “Efficacy and Safety of Homoharringtonine plus Cytarabine and Aclarubicin for Patients with Myelodysplastic Syndrome-RAEB.” Oncology Letters 11 (1): 355–59. doi:10.3892/ol.2015.3876.